|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 89, 428-438, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
DJ Hearse, C Erol, LA Robinson, MP Maxwell and MV Braimbridge
We have characterized an isolated rat heart preparation in which particles
induce transient coronary vasoconstriction. Exploiting the fact that all
commercially available intravenous solutions contain permissible levels of
contaminant particles (usually 2 to 20 micron in diameter), we investigated
whether these particles have any adverse effect upon coronary flow. A
commercially available intravenous solution was modified to produce the St.
Thomas' Hospital cardioplegic solution. Constant-pressure infusion of this
solution over a 20 minute period caused a 46.2% +/- 5.1% reduction in
coronary flow. This flow impairment could be limited to 13.3% +/- 3.5% by
the incorporation of a 0.8 micron in-line filter. In hearts perfused with
particle-containing solution followed by ultrafiltered solutions, the
impairment of coronary flow was reversed within 1 minute. This quick
reversal indicates that the particles were impairing flow not by physical
occlusion of vessels but by triggering some form of transient
vasoconstriction. In studies with filters of varying porosity (between 0.8
and 15.0 micron), the phenomenon was shown to be attributable to relatively
small numbers of particles greater than 10.0 micron in diameter. In studies
of myocardial protection, it was shown that the impairment of solution
delivery and distribution caused by particles could severely reduce the
protective properties of a chemical cardioplegic solution; hearts subjected
to 180 minutes of hypothermic (20 degrees C) ischemic arrest with multidose
(3 minutes every 30 minutes) cardioplegia recovered almost completely upon
reperfusion if a filtered (0.8 micron) solution was used, but failed to
recover when unfiltered, commercially prepared solutions were used. In an
attempt to define the mechanisms underlying the particle-induced
vasoconstriction, we conducted dose-response studies in which various
vasoactive agents were used in an attempt to combat the effects of the
particles. At their optimal concentrations, procaine (10.0 mmol/L),
nifedipine (0.1 mumol/L), and adenosine triphosphate (1.0 mmol/L)
completely prevented the problem; lidocaine and dipyridamole partially
alleviated the effect; verapamil and isosorbide dinitrate were ineffective.
These results indicate that several mechanisms acting at a small vessel
level might contribute to the particle-induced vasoconstriction.
ARTICLES
Particle-induced coronary vasoconstriction during cardioplegic infusion. Characterization and possible mechanisms
This article has been cited by other articles:
![]() |
E. Cozzi, S. Hazarika, H. W. Stallings III, W. E. Cascio, R. B. Devlin, R. M. Lust, C. J. Wingard, and M. R. Van Scott Ultrafine particulate matter exposure augments ischemia-reperfusion injury in mice Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H894 - H903. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Merkle, W. Bottcher, and R. Hetzer Prebypass filtration of cardiopulmonary bypass circuits: an outdated technique? Perfusion, January 1, 2003; 18(1_suppl): 81 - 88. [Abstract] [PDF] |
||||
![]() |
A M Knaapen, G J den Hartog, A Bast, and P J. Borm Ambient particulate matter induces relaxation of rat aortic rings in vitro Human and Experimental Toxicology, May 1, 2001; 20(5): 259 - 265. [Abstract] [PDF] |
||||
![]() |
T. Sendo, M. Hirakawa, K. Fujie, Y. Kataoka, and R. Oishi Contrast Medium–induced Pulmonary Edema Is Aggravated by Silicone Contamination in Rats Radiology, July 1, 1999; 212(1): 97 - 102. [Abstract] [Full Text] |
||||
![]() |
E. S. Yee and W.-R. Hsieh Ischemia-Activated Platelets in Normal and in Naturally Occurring Hypertrophied Myocardium Vascular and Endovascular Surgery, April 1, 1992; 26(3): 186 - 192. [Abstract] [PDF] |
||||
![]() |
L. Marshall Filtration in cardiopulmonary bypass: past, present and future Perfusion, April 1, 1988; 3(2): 135 - 147. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |